Logo image of INVZ

INNOVIZ TECHNOLOGIES LTD (INVZ) Stock Fundamental Analysis

NASDAQ:INVZ - Nasdaq - IL0011745804 - Common Stock - Currency: USD

0.9  -0.07 (-7.46%)

After market: 0.88 -0.02 (-2.22%)

Fundamental Rating

3

Overall INVZ gets a fundamental rating of 3 out of 10. We evaluated INVZ against 125 industry peers in the Electronic Equipment, Instruments & Components industry. INVZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INVZ shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year INVZ has reported negative net income.
INVZ had a negative operating cash flow in the past year.
In the past 5 years INVZ always reported negative net income.
In the past 5 years INVZ always reported negative operating cash flow.
INVZ Yearly Net Income VS EBIT VS OCF VS FCFINVZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

INVZ has a Return On Assets of -71.76%. This is amonst the worse of the industry: INVZ underperforms 87.20% of its industry peers.
INVZ's Return On Equity of -120.05% is on the low side compared to the rest of the industry. INVZ is outperformed by 83.20% of its industry peers.
Industry RankSector Rank
ROA -71.76%
ROE -120.05%
ROIC N/A
ROA(3y)-59.25%
ROA(5y)-67.39%
ROE(3y)-88.89%
ROE(5y)-96.81%
ROIC(3y)N/A
ROIC(5y)N/A
INVZ Yearly ROA, ROE, ROICINVZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

INVZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVZ Yearly Profit, Operating, Gross MarginsINVZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

6

2. Health

2.1 Basic Checks

INVZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INVZ has been increased compared to 1 year ago.
INVZ has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INVZ Yearly Shares OutstandingINVZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
INVZ Yearly Total Debt VS Total AssetsINVZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

INVZ has an Altman-Z score of -7.42. This is a bad value and indicates that INVZ is not financially healthy and even has some risk of bankruptcy.
INVZ has a Altman-Z score of -7.42. This is amonst the worse of the industry: INVZ underperforms 91.20% of its industry peers.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.42
ROIC/WACCN/A
WACC9.02%
INVZ Yearly LT Debt VS Equity VS FCFINVZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

INVZ has a Current Ratio of 2.98. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INVZ (2.98) is better than 66.40% of its industry peers.
INVZ has a Quick Ratio of 2.91. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
INVZ's Quick ratio of 2.91 is fine compared to the rest of the industry. INVZ outperforms 75.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.91
INVZ Yearly Current Assets VS Current LiabilitesINVZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.26% over the past year.
Looking at the last year, INVZ shows a quite strong growth in Revenue. The Revenue has grown by 16.25% in the last year.
Measured over the past years, INVZ shows a very strong growth in Revenue. The Revenue has been growing by 72.69% on average per year.
EPS 1Y (TTM)40.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
Revenue 1Y (TTM)16.25%
Revenue growth 3Y64.32%
Revenue growth 5Y72.69%
Sales Q2Q%146.42%

3.2 Future

INVZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.08% yearly.
INVZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 133.33% yearly.
EPS Next Y37.82%
EPS Next 2Y20.96%
EPS Next 3Y17.33%
EPS Next 5Y46.08%
Revenue Next Year125.97%
Revenue Next 2Y129.63%
Revenue Next 3Y101.26%
Revenue Next 5Y133.33%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVZ Yearly Revenue VS EstimatesINVZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 500M 1B 1.5B 2B
INVZ Yearly EPS VS EstimatesINVZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

INVZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INVZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVZ Price Earnings VS Forward Price EarningsINVZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVZ Per share dataINVZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as INVZ's earnings are expected to grow with 17.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.96%
EPS Next 3Y17.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INVZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVIZ TECHNOLOGIES LTD

NASDAQ:INVZ (5/21/2025, 8:06:36 PM)

After market: 0.88 -0.02 (-2.22%)

0.9

-0.07 (-7.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners24.35%
Inst Owner Change-2.17%
Ins Owners1.72%
Ins Owner ChangeN/A
Market Cap179.06M
Analysts80
Price Target2.37 (163.33%)
Short Float %10.87%
Short Ratio7.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.07%
Min EPS beat(2)-6.56%
Max EPS beat(2)20.7%
EPS beat(4)2
Avg EPS beat(4)2.35%
Min EPS beat(4)-20.87%
Max EPS beat(4)20.7%
EPS beat(8)4
Avg EPS beat(8)1.68%
EPS beat(12)6
Avg EPS beat(12)0.51%
EPS beat(16)6
Avg EPS beat(16)-24.75%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)0.84%
Revenue beat(4)3
Avg Revenue beat(4)16.44%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)42.03%
Revenue beat(8)6
Avg Revenue beat(8)13.98%
Revenue beat(12)6
Avg Revenue beat(12)-0.97%
Revenue beat(16)7
Avg Revenue beat(16)-9.23%
PT rev (1m)-6.69%
PT rev (3m)-15.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)31.16%
EPS NY rev (1m)4.79%
EPS NY rev (3m)32.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-34.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.38
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 2.27
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.12
BVpS0.4
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -71.76%
ROE -120.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.25%
ROA(5y)-67.39%
ROE(3y)-88.89%
ROE(5y)-96.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.67%
Cap/Sales 18.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.91
Altman-Z -7.42
F-Score4
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)143.46%
Cap/Depr(5y)143.66%
Cap/Sales(3y)141.33%
Cap/Sales(5y)109.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
EPS Next Y37.82%
EPS Next 2Y20.96%
EPS Next 3Y17.33%
EPS Next 5Y46.08%
Revenue 1Y (TTM)16.25%
Revenue growth 3Y64.32%
Revenue growth 5Y72.69%
Sales Q2Q%146.42%
Revenue Next Year125.97%
Revenue Next 2Y129.63%
Revenue Next 3Y101.26%
Revenue Next 5Y133.33%
EBIT growth 1Y23.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.01%
EBIT Next 3Y9.75%
EBIT Next 5Y20.26%
FCF growth 1Y18.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.3%
OCF growth 3YN/A
OCF growth 5YN/A